Related Experiment Video
Updated: Apr 15, 2026

09:50
Author Spotlight: Eco-friendly Photoluminescent Textile Authentication with Curcumin
Published on: December 22, 2023
2.5K
Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies
Brad J Douglass1, Dallas L Clouatre
1a EAS Consulting Group , Alexandria , Virginia.
Journal of the American College of Nutrition
|April 10, 2015
Summary
Turmeric
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Nutritional Science
Background:
- Turmeric and its curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) show therapeutic promise but suffer from poor bioavailability.
- Formulation strategies are emerging to enhance curcuminoid absorption and bioactivity, yet comparative data is lacking.
- Different formulations may impact individual curcuminoid absorption unevenly, affecting physiological properties.
Purpose of the Study:
- To evaluate and compare the bioavailability of various commercial curcumin ingredients.
- To provide data for informed recommendations to healthcare professionals and consumers.
Main Methods:
- Comparative analysis of pharmacokinetic parameters from bioavailability studies.
- Utilized relative mass efficiency (E) to compare formulations with varying curcuminoid content.
Main Results:
- A hydrophilic carrier dispersed curcuminoid formula demonstrated 45.9 times higher bioavailability than standard purified curcuminoids.
- This formulation showed 1.5 times the bioavailability of the next best commercial ingredient, a cyclodextrin complex, based on relative mass efficiency.
- Delivery strategies significantly impact curcuminoid bioavailability.
Conclusions:
- Curcuminoid bioavailability is significantly enhanced by specific delivery strategies.
- Total formula mass is a critical factor for practical considerations like dosing, cost, and space.
Related Concept Videos
Methods for Studying Drug Absorption: In vitro
809
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
809
Methods for Studying Drug Absorption: In situ
862
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
862
Factors Influencing Drug Absorption: Anatomical Parameters
877
Drug absorption involves the movement of drugs from the point of administration into the systemic circulation. Initially, Gastrointestinal (GI) motility propels the drug through the digestive tract and into the stomach. However, the stomach's high acidity and limited surface area restrict its role in drug absorption for most drugs. The drug then moves from the stomach to the small intestine via gastric emptying, which can be slowed by various factors, including interactions with other...
877
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
2.6K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
2.6K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
7.0K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
7.0K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
314
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
314

